Search results for combination product
The SPC alphabet: Are combination product SPCs precluded by Article 3(a), (c) and/or (d)? The SPC alphabet: Are combination product SPCs precluded by Article 3(a), (c) and/or (d)? Reviewed by Dr Rose Hughes on Monday, December 13, 2021 Rating: 5
New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) Reviewed by Dr Rose Hughes on Monday, March 07, 2022 Rating: 5
[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision [Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision Reviewed by Jocelyn Bosse on Thursday, February 13, 2025 Rating: 5
Would you like a side of Mr Justice Arnold on SPCs with your wind turbine? Teva v Gilead, Abraxis v Comptroller and Wobben v Siemens kick of 2017's patent cases Would you like a side of Mr Justice Arnold on SPCs with your wind turbine?  Teva v Gilead, Abraxis v Comptroller and Wobben v Siemens kick of 2017's patent cases Reviewed by Annsley Merelle Ward on Thursday, January 26, 2017 Rating: 5
Compulsive Reference Disorder: another SPC case heads for the Duchy -- Part I Compulsive Reference Disorder: another SPC case heads for the Duchy -- Part I Reviewed by Jeremy on Thursday, October 17, 2013 Rating: 5
Does the Irish Court of Appeal in Merck v Clonmel part ways from the CJEU's Santen Article 3(d) decision? Does the Irish Court of Appeal in Merck v Clonmel part ways from the CJEU's Santen Article 3(d) decision? Reviewed by Dr Rose Hughes on Monday, May 17, 2021 Rating: 5
Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE) Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE) Reviewed by Dr Rose Hughes on Tuesday, April 19, 2022 Rating: 5
Powered by Blogger.